American International Group’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
KCM
NAM
American International Group's ABEO Position: Q2 2021 in Review
American International Group sold out of Abeona Therapeutics (ABEO) in Q2 2021, closing a stake of 1,408 shares — an estimated $66 sold.
American International Group first reported a position in ABEO in Q2 2015 and held it in 20 quarters. The position peaked at $321K in Q2 2018. 70 funds tracked by Wall St. Rank hold ABEO as of Q2 2021.
- American International Group reported no remaining Abeona Therapeutics position as of Q2 2021 after selling out during the quarter.
- American International Group sold 1,408 Abeona Therapeutics shares in Q2 2021, an estimated $66.
- American International Group first reported a position in Abeona Therapeutics in Q2 2015 and held it in 20 quarters.
- American International Group's Abeona Therapeutics position peaked at $321K in Q2 2018.
- 70 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2021.
Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.